γδ T cells express activation markers in the central nervous system of mice with chronic-relapsing experimental autoimmune encephalomyelitis

Journal of Autoimmunity

Volumn 17, Issue 4, 2001, Pages 261-271

  Gao, Yan Ling ^a   Rajan, Alice J ^a   Raine, Cedric S ^a   Brosnan, Celia F ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Activation markers; Autoimmunity; Central nervous system; Gamma delta T cells

Indexed keywords

CD69 ANTIGEN; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 2 RECEPTOR; PADGEM PROTEIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; BIOLOGICAL MARKER; CD8 ANTIGEN; L SELECTIN; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; T LYMPHOCYTE ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; IMMUNOCYTOCHEMISTRY; IMMUNOPATHOGENESIS; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; ANIMAL; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; PATHOLOGY; PHYSIOLOGY; RECURRENT DISEASE; SPLEEN; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD8; ANTIGENS, CD95; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNOPHENOTYPING; L-SELECTIN; LYMPHOCYTE ACTIVATION; MICE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, INTERLEUKIN-2; RECURRENCE; SPLEEN; T-LYMPHOCYTE SUBSETS;

EID: 0035544358     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2001.0547     Document Type: Article

References (60)

1. Animal models for autoimmune demyelinating disorders of the nervous system
2. Experimental autoimmune encephalomyelitis as a model of immune-mediated CNS disease
3. Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis
4. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice
5. T-lymphocyte entry into the central nervous system
6. Cellular immune reactions in the CNS
7. Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis
8. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNA inflammation
9. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis
10. Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis
11. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells
12. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice
13. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis
14. A pathogenic role for gamma delta T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse
15. Decreased severity of myelin oligodendrocyte glycoprotein peptide 33-35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene
16. Adoptively transferred EAE in gamma delta T cell-knockout mice
17. The effect of gamma delta T cell depletion on cytokine gene expression in experimental allergic encephalomyelitis
18. Experimental autoimmune encephalomyelitis on the SJL mouse: Effect of gamma delta T cell depletion on chemokine and chemokine receptor expression in the central nervous system
19. Cytokine secretion by delta gamma and alpha beta T cells in monophasic experimental autoimmune encephalomyelitis
20. The activation antigen CD69
21. The CD69 receptor: A multipurpose cell-surface trigger for hematopoietic cells
22. The L-selectin adhesion system
23. Biology of the interleukin-2 receptor
24. Surface and intracellular interleukin-2 receptor expression on various resting and activated populations involved in cell-mediated immunity in human peripheral blood
25. Signal transduction of interleukin 2 in human natural killer cells: Involvement of the p561ck tyrosine kinase
26. Role of cytokines in autoimmunity
27. Role of Fas/FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease
28. Aggravation of murine experimental allergic encephalomyelitis by administration of T-cell receptor gammadelta-specific antibody
29. Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis
30. Presence of T cells with activated and memory phenotypes in inflammatory spinal cord lesions
31. Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis
32. Adhesion molecule phenotype of T lymphocytes in inflamed CNS
33. Early preferential stimulation of gamma delta T cells by TNF-alpha
34. Interleukin-12 activates human gamma delta T cells: Synergistic effect of tumor necrosis factor-alpha
35. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity
36. Challenging cytokine redundancy: Infammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor deficient mice
37. The critical role of IL-12 and the IL-12R beta 2 subunit in the generation of pathogenic autoreactive Th1 cells
38. Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation
39. IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infection
40. Requirement of the IL-2 receptor beta chain for the development of V gamma3 dendritic epidermal T cells
41. The instructive role of innate immunity in the acquired immune response
42. NKT cells: Facts, functions and fallacies
43. Innate immunity and autoimmunity: From self-protection to self-destruction
44. Proinflammatory and immunoregulatory functions of interleukin-12
45. Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors
46. The gamma delta T-cell bridge: Linking innate and acquired immunity
47. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes
48. Activation of C-C beta-chemokines in human peripheral blood gamma delta T cells by isopentenyl pyrophosphate and regulation by cytokines
49. Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma delta T cells in vivo
50. Cell death during autoimmune demyelination: Effector but not target cells are eliminated by apoptosis
51. Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance
52. Expression of the Fas ligand in cells of T cell lineage
53. + synovial T cells by borrelia-reactive Fas-ligand(high) gamma delta T cells in Lyme arthritis
54. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions
55. Experimental autoimmune encephalomyelitis. Qualitative and semiquantitative differences in heat shock protein 60 expression in the central nervous system
56. + T cells as a mechanism for remission from experimental allergic encephalomyelitis
57. Isolation and characterization of cells infiltrating the spinal cord during the curse of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse
58. Modulation of experimental allergic encephalomyelitis in mice by immunization with a peptide specific for the gamma delta T cell receptor
59. Antigen recognition by human gamma delta T lymphocytes
60. γδ T cells: A right time and a right place for a conserved third way of protection